Cargando…

Prognostic signature and immune efficacy of m(1)A‐, m(5)C‐ and m(6)A‐related regulators in cutaneous melanoma

Cutaneous melanoma (CM) is an aggressive cancer; given that initial and specific signs are lacking, diagnosis is often late and the prognosis is poor. RNA modification has been widely studied in tumour progression. Nevertheless, little progress has been made in the signature of N(1)‐methyladenosine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Xian rui, Chen, Zheng, Liu, Yang, Chen, Zi zi, Tang, Fengjie, Chen, Zhi zhao, Li, Jing jing, Liao, Jun lin, Cao, Ke, Chen, Xiang, Zhou, Jianda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419166/ https://www.ncbi.nlm.nih.gov/pubmed/34288419 http://dx.doi.org/10.1111/jcmm.16800

Ejemplares similares

Prognostic Value of Dynactin mRNA Expression in Cutaneous Melanoma
por: Wang, Qiaoqi, et al.
Publicado: (2018)

Development of a Four-mRNA Expression-Based Prognostic Signature for Cutaneous Melanoma
por: Bai, Haiya, et al.
Publicado: (2021)

Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma
por: Rong, Jielin, et al.
Publicado: (2022)

Identification of the m(6)A RNA Methylation Regulators WTAP as a Novel Prognostic Biomarker and Genomic Alterations in Cutaneous Melanoma
por: Feng, Zi-Yi, et al.
Publicado: (2021)

Prognostic Implications of Metabolism Related Gene Signature in Cutaneous Melanoma
por: Zeng, Furong, et al.
Publicado: (2020)

The Prognostic Value of HRAS mRNA Expression in Cutaneous Melanoma
por: Wan, Xiaohua, et al.
Publicado: (2017)

M6A-Related Bioinformatics Analysis Reveals a New Prognostic Risk Signature in Cutaneous Malignant Melanoma
por: Yu, Qingxiong, et al.
Publicado: (2022)

Distinct prognostic value of mRNA expression of guanylate-binding protein genes in skin cutaneous melanoma
por: Wang, Qiaoqi, et al.
Publicado: (2018)

Integration Analysis of m6A Related Genes in Skin Cutaneous Melanoma and the Biological Function Research of the SPRR1B
por: Shi, Shupeng, et al.
Publicado: (2021)

m5C-Related Signatures for Predicting Prognosis in Cutaneous Melanoma with Machine Learning
por: Huang, Maoxin, et al.
Publicado: (2021)

Single cell sequencing analysis constructed the N7-methylguanosine (m7G)-related prognostic signature in uveal melanoma
por: Xie, Jiaheng, et al.
Publicado: (2023)

Synergistic Effect of Repolarization of M2 to M1 Macrophages Induced by Iron Oxide Nanoparticles Combined with Lactate Oxidase
por: Liao, Zi-Xian, et al.
Publicado: (2021)

The m(6)A-methylated mRNA pattern and the activation of the Wnt signaling pathway under the hyper-m(6)A-modifying condition in the keloid
por: Lin, Can-Xiang, et al.
Publicado: (2022)

Corrigendum: The m(6)A-methylated mRNA pattern and the activation of the Wnt signaling pathway under the hyper-m(6)A-modifying condition in the keloid
por: Lin, Can-Xiang, et al.
Publicado: (2023)

The prognostic values of m6A RNA methylation regulators in uveal melanoma
por: Tang, Jing, et al.
Publicado: (2020)

DFT study on the adsorption of 5-fluorouracil on B(40), B(39)M, and M@B(40) (M = Mg, Al, Si, Mn, Cu, Zn)
por: Zhang, Li, et al.
Publicado: (2021)

m6A-immune-related lncRNA prognostic signature for predicting immune landscape and prognosis of bladder cancer
por: Feng, Zi-Hao, et al.
Publicado: (2022)

Development and validation of an m6A RNA methylation regulator-based signature for the prediction of prognosis and immunotherapy in cutaneous melanoma
por: Li, Tingting, et al.
Publicado: (2023)

Establishment of a new molecular subtyping and prognostic signature with m6A/m5C/m1A/m7G regulatory genes for hepatocellular carcinoma
por: Liu, Ting, et al.
Publicado: (2023)

Role of m6A methyltransferase component VIRMA in multiple human cancers (Review)
por: Zhu, Wei, et al.
Publicado: (2021)

Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma
por: Jin, Yi, et al.
Publicado: (2021)

Construction of autophagy prognostic signature and analysis of prospective molecular mechanisms in skin cutaneous melanoma patients
por: Liao, Shian, et al.
Publicado: (2021)

The prognostic value and immune landscaps of m6A/m5C-related lncRNAs signature in the low grade glioma
por: Li, Ran, et al.
Publicado: (2023)

Development and validation of a m(6)A -regulated prognostic signature in lung adenocarcinoma
por: Chen, Yaxin, et al.
Publicado: (2022)

Prognostic values of inhibitory κB kinases mRNA expression in human gastric cancer
por: Gayed, David Timothy, et al.
Publicado: (2019)

Identification of cross-talk between m(6)A and 5mC regulators associated with onco-immunogenic features and prognosis across 33 cancer types
por: Chen, Yu-Tong, et al.
Publicado: (2020)

Construction of miRNA-mRNA Regulatory Network and Prognostic Signature in Endometrial Cancer
por: Sun, Rui, et al.
Publicado: (2021)

Prognostic and predictive value of a mRNA signature in peripheral T‐cell lymphomas: A mRNA expression analysis
por: Tu, Jiannan, et al.
Publicado: (2020)

Identification of m6A modification patterns and development of m6A–hypoxia prognostic signature to characterize tumor microenvironment in triple-negative breast cancer
por: Shen, Xi, et al.
Publicado: (2022)

Identification of a five‐mRNA signature as a novel potential prognostic biomarker in pediatric Wilms tumor
por: Lin, Xiao‐Dan, et al.
Publicado: (2019)

Four m6A RNA Methylation Gene Signatures and Their Prognostic Values in Lung Adenocarcinoma
por: Wang, Yuzhu, et al.
Publicado: (2022)

The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinoma
por: Liu, Ting, et al.
Publicado: (2023)

Identification of three m6A‐related mRNAs signature and risk score for the prognostication of hepatocellular carcinoma
por: Li, Zedong, et al.
Publicado: (2020)

Corrigendum: Development and validation of a m(6)A -regulated prognostic signature in lung adenocarcinoma
por: Chen, Yaxin, et al.
Publicado: (2023)

Construction and Validation of an m6A RNA Methylation Regulators-Based Prognostic Signature for Esophageal Cancer
por: Xu, Li-chao, et al.
Publicado: (2020)

Prognostic Value of an m6A RNA Methylation Regulator-Based Signature in Patients with Hepatocellular Carcinoma
por: Wu, Xiaomin, et al.
Publicado: (2020)

Identification of an m6A Regulators-Mediated Prognosis Signature For Survival Prediction and Its Relevance to Immune Infiltration in Melanoma
por: Wu, Liuxing, et al.
Publicado: (2021)

The efficacy of (99m)Tc-rituximab as a tracer for sentinel lymph node biopsy in cutaneous melanoma patients
por: Liu, Jiayong, et al.
Publicado: (2022)

Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme
por: Yang, Ji’an, et al.
Publicado: (2020)

Constructing and validating of m6a-related genes prognostic signature for stomach adenocarcinoma and immune infiltration: Potential biomarkers for predicting the overall survival
por: Yang, Jing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_22n5nte9ock81dlgj1u9sm1585